Superworth

Bio-Rad Laboratories PE ratio BIO

Share price divided by earnings per share over the last twelve months, since 2011.

Today, Nov 2, 2026
44.4×
10-year median
30.9×
Against its 10-year history
54th
percentile: 0 is its lowest day, 100 its highest
10-year range
5.3× to 457×
Peer median
37.0×

Bio-Rad Laboratories' PE ratio is 44.4× as of Nov 2, 2026: a share price of $366.16 against $8.25 of earnings per share over the last twelve months.

That is above its ten-year median of 30.9×, close to the middle of its last ten years.

Over that time it ranged from 5.3× in Dec 2018 to 457× in Sep 2017.

The median for 10 diagnostics and research stocks of a similar size is 37.0×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far44.4×10.0×53.6×
202528.9×22.5×28.9×
2024n/m a value too high to mean anything
2023n/m a value too high to mean anything
2022n/m a value too high to mean anything
2021n/m a value too high to mean anything
202010.1×10.1×33.1×
201930.2×5.4×30.7×
20185.4×5.3×347×
2017302×56.0×457×
201654.7×34.3×55.1×
201539.5×38.5×46.2×
201444.0×39.4×57.4×
201340.2×17.1×40.2×
201216.4×14.8×17.9×
201114.6×13.7×19.1×

Against its peers

Companies in Medical - Diagnostics & Research nearest Bio-Rad Laboratories' size, closest first, today.

CompanyPE ratio
BIOBio-Rad Laboratories44.4×
CAICaris Life Sciences86.8×
LNTHLantheus24.3×
RVTYRevvity72.2×
MEDPMedpace38.0×
BLLNBillionToOne170×
CDNACareDx35.9×
VCYTVeracyte35.0×
DGXQuest Diagnostics24.9×
LHLabcorp29.4×
MTDMettler-Toledo International38.4×
Peer median37.0×

Where Bio-Rad Laboratories ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Bio-Rad Laboratories

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.